SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Jongmans who wrote (295)5/29/1998 12:11:00 PM
From: Jongmans  Read Replies (1) | Respond to of 4474
 
ARIAD's GENE expression technolgy featured at the American Society Of Gene Therapy Meeting

See announcement at PRNewswire ,time 11.35

Martin



To: Jongmans who wrote (295)5/29/1998 3:43:00 PM
From: Czechsinthemail  Read Replies (2) | Respond to of 4474
 
What are the thoughts on the TRIDENT collaboration? Does anyone have information on how much ARIA will be contributing or what its costs will be? I'm a bit concerned about another project that will eat cash but not show results for a long time. Is this likely to be a big boon for ARIA?
Baird



To: Jongmans who wrote (295)5/30/1998 11:27:00 AM
From: Steve Lokness  Read Replies (1) | Respond to of 4474
 
Martin;
Can you help me understand what this is all about? Who is Argonaut Technology? The other members of the Trident Library Synthesizer System are really big players, how will Ariad be able to fund their share and take advantage of it. Why did Ariad not make an announcement of their own on this project?

Thanks;
Steve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News